Stocks To Buy Now

Blog

The Stocks To Buy Now Blog

Our team has been covering the micro- and small-cap markets for more than a decade, exploring a wide variety of trends, technology and news in every industry. The Stocks to Buy Now blog seeks out undervalued companies, covers their news, breaks down the jargon, and delivers accurate and timely information to you on a daily basis.

If you’re looking for market insight, undervalued gems, and an assortment of investment options, read on.

Argentina Proving to be a Land of Opportunity for Marifil Mines Ltd. (TSX.V: MFM) (OTCQB: MFMLF)

Marifil Mines’ primary exploration goals involve high-demand gold, lithium and cobalt targets Argentina is the third-largest gold producer in South America and anticipates most of its geological potential has yet to be tapped Canada-based Marifil has numerous project sites throughout Argentina in search for gold, lithium, cobalt, nickel, platinum, silver, phosphate and potassium Argentina’s nascent […]

Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Infuses Cannabis Industry, Delivers Results with Innovative Drug Delivery Platform

Global legal cannabis market projected to surpass $146 billion by end of 2025 Cannabinoid-infused edibles, concentrates represent fastest-growing segment of industry Lexaria’s patented technology improves bio-absorption and bioavailability of active ingredients while masking unpleasant taste Lucrative licensing business model includes agreements to enhance cannabinoid (CBD) delivery before year-end 2018 Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: […]

VistaGen Therapeutics, Inc. (NASDAQ: VTGN) Moves Forward in Developing As-Needed Treatment for Social Anxiety Disorder

Company signs a worldwide licensing agreement with Pherin Pharmaceuticals for the development and commercialization of a Phase 3-ready CNS drug candidate for as-needed treatment of social anxiety disorder Untreated social anxiety disorder has a significant impact on a person’s overall quality of life Clinical studies support the potential of PH94B to be a superior treatment […]

ChineseInvestors.com, Inc.’s (CIIX) CBD Biotechnology Co. Ltd. Sets December Launch for CBD Hemp-Infused Rice Wine, Sees it as ‘Sales Driver’

CIIX’s wholly owned foreign enterprise, CBD Biotechnology Co. Ltd. (CBD Biotech), will debut new private label wine at peak period for liquor sales in China Company recorded sales of $2.35 million for FY2018, up 41 percent from $1.66 million the prior year Summer Yun, CEO of CBD Biotech, anticipates greater volume during the top sales […]

DEA Decision to Remove Some Cannabidiol from Most Restrictive Class of Controlled Substances May Have Far-Reaching Impact on the CBD Market

The U.S. Drug Enforcement Administration (DEA) ruling enables physicians to prescribe Epidiolex, a non-synthetic cannabis-derived medicine from United Kingdom-grown cannabis Cannabis entrepreneurs applaud the decision, even though it only applies to that specific drug; DEA decision requires approval of medications by the U.S. Food & Drug Administration (FDA) Several other CBD medications are in the […]

Green Hygienics Holdings Inc. (GRYN) Acquires Canna Brands Portfolio

The three online platforms provide a strategic step forward in advancing the company’s business model by creating tools to introduce the existing portfolio brands into vertical markets Again the company is setting itself apart by further demonstrating a unique business approach toward advancing operations and creating value in the sector The acquisition portfolio has the […]

BLOCKStrain Technology Corp. (TSX.V: DNAX) (OTC: BKKSF) Signs Partnership with Lighthouse Genomics, Inc.

Technology partnership signed with Integral Genomics Inc. (dba Lighthouse Genomics Inc.) to support BLOCKStrain’s registry of genetic profiles of cannabis strains Valuable intellectual property rights of cannabis cultivators under attack from unscrupulous illegal growers, gray market Recent reschedule of first FDA-approved drug derived from cannabis paves the way for sales, underscores necessity of BLOCKStrain’s “Single […]

 

From Our Blog

Cardio Diagnostics Holdings Inc. (NASDAQ: CDIO) Brings Molecular Precision to a Blind Spot in Coronary Heart Disease (‘CHD’) Detection

June 26, 2026

Coronary heart disease (“CHD”) remains the leading cause of death in the United States, but the tools doctors have long relied on to detect it early are proving less reliable than many patients assume. Cardio Diagnostics Holdings (NASDAQ: CDIO) reports that approximately 50% of individuals with coronary heart disease do not present with traditional risk […]

Rotate your device 90° to view site.